Japan Transfusion Diagnostics Market to 2021: Immunohematology and NAT Testing--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Emerging Opportunities
Complete report $7,700. DataPack (test volumes, sales forecasts, supplier shares) $4,950.
VPGMarketResearch.coms new report is a strategic analysis prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.
RationaleDuring the nextfive years, the Japanese blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.
Strategic Recommendations- New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi- automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years.
Blood Typing and Grouping TestsABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).
Infectious Disease Screening TestsAIDS (HIV NAT, HIV- 1/2), Cytomegalovirus,Hepatitis (HAV NAT, HBV NAT, HBs Ag,Anti- HBc, HCV NAT, HCV, ALT/SGPT), HTLV- I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.
Sales and Market Share AnalysisSales and market share estimates of leadingsuppliers of blood banking of reagentsand instruments, by individual product.
Competitive AssessmentsStrategic assessments of major suppliers and emerging market entrants, including their sales,product portfolios, marketing tactics, and newproducts in R&D.
Market Segmentation Analysis- Comprehensive market segmentationanalysis, including review of the marketdynamics, trends, structure, size, growth,and key suppliers. - Test volume and sales forecasts for over 40 blood banking tests, including NAT, by market segment:- Blood Centers- Hospitals- Commercial/Private LaboratoriesCurrent and Emerging Products- Analysis of current and emerging blood banking tests. - Review of automated and semi- automatedanalyzers, including their operatingcharacteristics, features, and selling prices.
Technology Review- Assessment of current and emerging technologies,and their potential applications for the blood banking market. - Comprehensive lists of companies developingor marketing new technologies and products by test. Contains 426 pages and 41 tables
VPGMarketResearch.coms new report is a strategic analysis prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.
RationaleDuring the nextfive years, the Japanese blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.
Strategic Recommendations- New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi- automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years.
Blood Typing and Grouping TestsABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).
Infectious Disease Screening TestsAIDS (HIV NAT, HIV- 1/2), Cytomegalovirus,Hepatitis (HAV NAT, HBV NAT, HBs Ag,Anti- HBc, HCV NAT, HCV, ALT/SGPT), HTLV- I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.
Sales and Market Share AnalysisSales and market share estimates of leadingsuppliers of blood banking of reagentsand instruments, by individual product.
Competitive AssessmentsStrategic assessments of major suppliers and emerging market entrants, including their sales,product portfolios, marketing tactics, and newproducts in R&D.
Market Segmentation Analysis- Comprehensive market segmentationanalysis, including review of the marketdynamics, trends, structure, size, growth,and key suppliers. - Test volume and sales forecasts for over 40 blood banking tests, including NAT, by market segment:- Blood Centers- Hospitals- Commercial/Private LaboratoriesCurrent and Emerging Products- Analysis of current and emerging blood banking tests. - Review of automated and semi- automatedanalyzers, including their operatingcharacteristics, features, and selling prices.
Technology Review- Assessment of current and emerging technologies,and their potential applications for the blood banking market. - Comprehensive lists of companies developingor marketing new technologies and products by test. Contains 426 pages and 41 tables
I. INTRODUCTION
II. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary
III. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
IV. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
V. Worldwide Technology and Market Overview
A.Major Blood Typing, Grouping and Infectious Disease Screening Tests
1. BLOOD TYPING AND GROUPING TESTS
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. INFECTIOUS DISEASE SCREENING TESTS
a. AIDS/HIV
Background
Diagnostic Tests
Enzyme Immunoassay
Viral Load/Drug Resistance Testing
Genotype and Phenotype Testing
Blood Banking Considerations
b. Hepatitis Markers
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D (Delta Hepatitis)
Hepatitis E
Hepatitis G
Vaccines and Drugs
c. Cytomegalovirus
Background
Diagnostic Tests
Vaccines and Drugs
d. Syphilis
Background
Diagnostic Tests
Vaccines and Drugs
e. West Nile Virus
Background
Clinical Syndromes
Diagnostic Tests
Vaccines and Drugs
f. Parvovirus B19
Microbiology
Epidemiology
Clinical Syndromes
Diagnostic Test
Vaccines and Drugs
g. Creutzfeldt-Jakob’s Disease
Background
Transmission
Diagnostic Tests
Vaccines and Drugs
h. Malaria
i. Chagas Disease
j. Babesiosis
3. PATHOGEN REDUCTION
4. LEUKOCYTE REDUCTION
Background
Methods
B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Blood Typing, Grouping and Infectious Disease Screening Automated and Semiautomated Analyzers
C.Major Blood Banking Technologies and Their Potential Applications
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL AND POLYCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. MICROTITRATION PLATES
5. IT AND AUTOMATION
6. LASERS
7. ROBOTICS
8. SYNTHETIC RED CELL SUBSTITUTES
9. GENETICALLY ENGINEERED BLOOD COMPONENTS
10. BLOOD PRESERVATION
11. AUTOLOGOUS BLOOD TRANSFUSION/FREEZING
VI. Japan Blood Banking Market
A. EXECUTIVE SUMMARY
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,Major Supplier Sales and Market Shares
VII. Competitive Assessments
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Hologic/Gen-Probe
Grifols
Immucor
Ortho-Clinical Diagnostics
Proteome Sciences
Quest Diagnostics
Quidel
Roche
Siemens
Tecan
II. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary
III. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
IV. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
V. Worldwide Technology and Market Overview
A.Major Blood Typing, Grouping and Infectious Disease Screening Tests
1. BLOOD TYPING AND GROUPING TESTS
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. INFECTIOUS DISEASE SCREENING TESTS
a. AIDS/HIV
Background
Diagnostic Tests
Enzyme Immunoassay
Viral Load/Drug Resistance Testing
Genotype and Phenotype Testing
Blood Banking Considerations
b. Hepatitis Markers
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D (Delta Hepatitis)
Hepatitis E
Hepatitis G
Vaccines and Drugs
c. Cytomegalovirus
Background
Diagnostic Tests
Vaccines and Drugs
d. Syphilis
Background
Diagnostic Tests
Vaccines and Drugs
e. West Nile Virus
Background
Clinical Syndromes
Diagnostic Tests
Vaccines and Drugs
f. Parvovirus B19
Microbiology
Epidemiology
Clinical Syndromes
Diagnostic Test
Vaccines and Drugs
g. Creutzfeldt-Jakob’s Disease
Background
Transmission
Diagnostic Tests
Vaccines and Drugs
h. Malaria
i. Chagas Disease
j. Babesiosis
3. PATHOGEN REDUCTION
4. LEUKOCYTE REDUCTION
Background
Methods
B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Blood Typing, Grouping and Infectious Disease Screening Automated and Semiautomated Analyzers
C.Major Blood Banking Technologies and Their Potential Applications
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL AND POLYCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. MICROTITRATION PLATES
5. IT AND AUTOMATION
6. LASERS
7. ROBOTICS
8. SYNTHETIC RED CELL SUBSTITUTES
9. GENETICALLY ENGINEERED BLOOD COMPONENTS
10. BLOOD PRESERVATION
11. AUTOLOGOUS BLOOD TRANSFUSION/FREEZING
VI. Japan Blood Banking Market
A. EXECUTIVE SUMMARY
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,Major Supplier Sales and Market Shares
VII. Competitive Assessments
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Hologic/Gen-Probe
Grifols
Immucor
Ortho-Clinical Diagnostics
Proteome Sciences
Quest Diagnostics
Quidel
Roche
Siemens
Tecan
LIST OF TABLES
Major Companies Developing or Marketing Blood Typing and Grouping Tests
Major Companies Developing or Marketing HLA Typing Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Blood Bank Analyzers
Executive Summary Table:Japan, Total Blood Bank Test Volume and Reagent Sales Forecast by Test Category
Japan, Facilities Performing Blood Bank Tests by Market Segment
Japan, Hospital Laboratories Performing Blood Bank Tests By Bed Size
Japan, Commercial/Private Laboratories Performing Blood Bank Tests by Annual Test Volume
Japan, All Market Segments Blood Typing and Grouping Test Volume Forecast by Market Segment
Japan, All Market Segments Blood Typing and Grouping Test Volume Forecast
Japan, Hospital Laboratories Blood Typing and Grouping Test Volume Forecast
Japan, Blood Banks Blood Typing and Grouping Test Volume Forecast
Japan, Commercial/Private Laboratories Blood Typing and Grouping Test Volume Forecast
Japan, All Market Segments Infectious Disease Screening Test Volume Forecast by Market Segment
Japan, All Market Segments Infectious Disease Screening Test Volume Forecast
Japan, Blood Banks Infectious Disease Screening Test Volume Forecast
Japan, Commercial/Private Laboratories Infectious Disease Screening Test Volume Forecast
Japan, Hospital Laboratories Infectious Disease Screening Test Volume Forecast
Japan, All Market Segments Blood Typing and Grouping Reagent Market Forecast By Market Segment
Japan, All Market Segments Blood Typing And Grouping Reagent Market Forecast byMajor Test
Japan, Hospital Laboratories Blood Typing and Grouping Reagent Market Forecast ByMajor Test
Japan, Blood Banks Blood Typing and Grouping Reagent Market ByMajor Test Forecast
Japan, Commercial/Private Laboratories Blood Typing and Grouping Reagent Market Forecast ByMajor Test
Japan, All Market Segments Infectious Disease Screening Reagent Market Forecast By Market Segment
Japan, All Market Segments Infectious Disease Screening Reagent Market Forecast by Test
Japan, Blood Banks Infectious Disease Screening Reagent Market Forecast by Test
Japan, Commercial/Private Laboratories Infectious Disease Screening Reagent Market Forecast By Test
Japan, Hospital Laboratories Infectious Disease Screening Reagent Market Forecast by Test
Japan,Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares
Japan, HIV/HTLV Blood Screening Market, Reagent Sales byMajor Supplier
Japan, Hepatitis C Blood Screening Market, Reagent Sales byMajor Supplier
Japan, CMV Blood Screening Market, Reagent Sales byMajor Supplier
Japan, Syphilis Blood Screening Market, Reagent Sales byMajor Supplier
Major Companies Developing or Marketing Blood Typing and Grouping Tests
Major Companies Developing or Marketing HLA Typing Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Blood Bank Analyzers
Executive Summary Table:Japan, Total Blood Bank Test Volume and Reagent Sales Forecast by Test Category
Japan, Facilities Performing Blood Bank Tests by Market Segment
Japan, Hospital Laboratories Performing Blood Bank Tests By Bed Size
Japan, Commercial/Private Laboratories Performing Blood Bank Tests by Annual Test Volume
Japan, All Market Segments Blood Typing and Grouping Test Volume Forecast by Market Segment
Japan, All Market Segments Blood Typing and Grouping Test Volume Forecast
Japan, Hospital Laboratories Blood Typing and Grouping Test Volume Forecast
Japan, Blood Banks Blood Typing and Grouping Test Volume Forecast
Japan, Commercial/Private Laboratories Blood Typing and Grouping Test Volume Forecast
Japan, All Market Segments Infectious Disease Screening Test Volume Forecast by Market Segment
Japan, All Market Segments Infectious Disease Screening Test Volume Forecast
Japan, Blood Banks Infectious Disease Screening Test Volume Forecast
Japan, Commercial/Private Laboratories Infectious Disease Screening Test Volume Forecast
Japan, Hospital Laboratories Infectious Disease Screening Test Volume Forecast
Japan, All Market Segments Blood Typing and Grouping Reagent Market Forecast By Market Segment
Japan, All Market Segments Blood Typing And Grouping Reagent Market Forecast byMajor Test
Japan, Hospital Laboratories Blood Typing and Grouping Reagent Market Forecast ByMajor Test
Japan, Blood Banks Blood Typing and Grouping Reagent Market ByMajor Test Forecast
Japan, Commercial/Private Laboratories Blood Typing and Grouping Reagent Market Forecast ByMajor Test
Japan, All Market Segments Infectious Disease Screening Reagent Market Forecast By Market Segment
Japan, All Market Segments Infectious Disease Screening Reagent Market Forecast by Test
Japan, Blood Banks Infectious Disease Screening Reagent Market Forecast by Test
Japan, Commercial/Private Laboratories Infectious Disease Screening Reagent Market Forecast By Test
Japan, Hospital Laboratories Infectious Disease Screening Reagent Market Forecast by Test
Japan,Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares
Japan, HIV/HTLV Blood Screening Market, Reagent Sales byMajor Supplier
Japan, Hepatitis C Blood Screening Market, Reagent Sales byMajor Supplier
Japan, CMV Blood Screening Market, Reagent Sales byMajor Supplier
Japan, Syphilis Blood Screening Market, Reagent Sales byMajor Supplier
